Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

Ar­bor Biotech­nolo­gies is trim­ming its ear­ly-stage dis­cov­ery work, lead­ing to lay­offs in the group.

The move was con­firmed by an Ar­bor spokesper­son, with CEO De­vyn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA